Although the detailed mechanism is still undefined, earlier studies have suggested that reactive oxygen species (ROS) and hypoxia-inducible transcription factor 1α (HIF-1α) are potential mediators of cycling hypoxia-mediated tumor progression and radiotherapy resistance [4], [5]. The gene discussed is HIF1A; the disease is neoplasm.